A detailed history of Quantbot Technologies LP transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Quantbot Technologies LP holds 10,311 shares of HRMY stock, worth $268,292. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,311
Previous 28,413 63.71%
Holding current value
$268,292
Previous $943,000 65.54%
% of portfolio
0.01%
Previous 0.03%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025

SELL
$27.94 - $35.91 $505,769 - $650,042
-18,102 Reduced 63.71%
10,311 $325,000
Q1 2025

May 13, 2025

BUY
$32.18 - $40.46 $723,631 - $909,824
22,487 Added 379.46%
28,413 $943,000
Q4 2024

Feb 11, 2025

BUY
$31.86 - $41.49 $129,765 - $168,988
4,073 Added 219.81%
5,926 $203,000
Q3 2024

Nov 13, 2024

BUY
$30.0 - $39.95 $55,590 - $74,027
1,853 New
1,853 $74,000
Q1 2024

May 06, 2024

BUY
$29.93 - $35.06 $249,705 - $292,505
8,343 Added 129.03%
14,809 $497,000
Q4 2023

Feb 14, 2024

BUY
$19.2 - $33.78 $124,147 - $218,421
6,466 New
6,466 $208,000
Q2 2023

Aug 08, 2023

BUY
$30.5 - $37.4 $143,899 - $176,453
4,718 New
4,718 $166,000
Q4 2022

Feb 13, 2023

SELL
$45.4 - $60.91 $28,829 - $38,677
-635 Reduced 15.67%
3,417 $188,000
Q3 2022

Nov 07, 2022

BUY
$42.06 - $55.45 $24,226 - $31,939
576 Added 16.57%
4,052 $179,000
Q2 2022

Aug 09, 2022

SELL
$33.54 - $52.15 $233,136 - $362,494
-6,951 Reduced 66.66%
3,476 $169,000
Q1 2022

May 16, 2022

BUY
$33.14 - $51.13 $282,584 - $435,985
8,527 Added 448.79%
10,427 $507,000
Q4 2021

Feb 11, 2022

BUY
$34.09 - $43.91 $64,771 - $83,429
1,900 New
1,900 $81,000

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $1.54B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.